Patents by Inventor Johan NORD

Johan NORD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bis(sulfonamide) derivatives and their use as mPGES inhibitors
    Patent number: 10227296
    Abstract: The present invention relates to bis(sulfonamide) compounds and pharmaceutically acceptable salts thereof. The present invention also relates to pharmaceutical compositions comprising these compounds and to their use as a medicament for the treatment and/or prevention of a disease, disorder or condition in which modulation of microsomal prostaglandin E synthase-1 activity is beneficial, such as pain, inflammation and cancer.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: March 12, 2019
    Assignee: Arcturum Real Estate AB
    Inventors: Peter Söderman, Mats A. Svensson, Annika Kers, Liselott Öhberg, Katharina Högdin, Andreas Hettman, Jesper Hallberg, Maria Ek, Johan Bylund, Johan Nord
  • Bis(sulfonamide) derivatives and their use as mPGES inhibitors
    Patent number: 10081614
    Abstract: The present invention relates to bis(sulfonamide) compounds and pharmaceutically acceptable salts thereof. The present invention also relates to pharmaceutical compositions comprising these compounds and to their use as a medicament for the treatment and/or prevention of a disease, disorder or condition in which modulation of microsomal prostaglandin E synthase-1 activity is beneficial, such as pain, inflammation and cancer.
    Type: Grant
    Filed: November 24, 2015
    Date of Patent: September 25, 2018
    Assignee: ACTURUM REAL ESTATE AB
    Inventors: Peter Söderman, Mats A. Svensson, Annika Kers, Liselott Öhberg, Katharina Högdin, Andreas Hettman, Jesper Hallberg, Maria Ek, Johan Bylund, Johan Nord
  • BIS(SULFONAMIDE) DERIVATIVES AND THEIR USE AS MPGES INHIBITORS
    Publication number: 20180002278
    Abstract: The present invention relates to bis(sulfonamide) compounds and pharmaceutically acceptable salts thereof. The present invention also relates to pharmaceutical compositions comprising these compounds and to their use as a medicament for the treatment and/or prevention of a disease, disorder or condition in which modulation of microsomal prostaglandin E synthase-1 activity is beneficial, such as pain, inflammation and cancer.
    Type: Application
    Filed: November 24, 2015
    Publication date: January 4, 2018
    Inventors: Peter SÖDERMAN, Mats A. SVENSSON, Annika KERS, Liselott ÖHBERG, Katharina HÖGDIN, Andreas HETTMAN, Jesper HALLBERG, Maria EK, Johan BYLUND, Johan NORD
  • BIS(SULFONAMIDE) DERIVATIVES AND THEIR USE AS MPGES INHIBITORS
    Publication number: 20170313672
    Abstract: The present invention relates to bis(sulfonamide) compounds and pharmaceutically acceptable salts thereof. The present invention also relates to pharmaceutical compositions comprising these compounds and to their use as a medicament for the treatment and/or prevention of a disease, disorder or condition in which modulation of microsomal prostaglandin E synthase-1 activity is beneficial, such as pain, inflammation and cancer.
    Type: Application
    Filed: November 24, 2015
    Publication date: November 2, 2017
    Inventors: Peter SÖDERMAN, Mats A. SVENSSON, Annika KERS, Liselott ÖHBERG, Katharina HÖGDIN, Andreas HETTMAN, Jesper HALLBERG, Maria EK, Johan BYLUND, Johan NORD